Agrecan and articular cartilage: Assessment of glycosyltransferases for the restoration of cartilage matrix in osteoarthritis;L'agrécane et le cartilage articulaire: Apport des glycosyltransférases dans la réparation du cartilage arthrosique

Journal de la Societe de Biologie

Volumn 202, Issue 4, 2008, Pages 281-288

  Magdalou, Jacques ^a   Netter, Patrick ^a   Fournel Gigleux, Sylvie ^a   Ouzzine, Mohamed ^a  

^a CNRS   (France)

Author keywords

Aggrecan; Arthropathies; Cartilage; Glycosyltransferases

Indexed keywords

AGGRECAN; GLYCOSYLTRANSFERASE;

ANIMAL; ANIMAL MODEL; ARTICLE; ARTICULAR CARTILAGE; DRUG EFFECT; ENZYMOLOGY; HISTOLOGY; HUMAN; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; PHYSIOLOGY; SYNOVIUM;

AGGRECANS; ANIMALS; CARTILAGE, ARTICULAR; GLYCOSYLTRANSFERASES; HUMANS; MODELS, ANIMAL; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 65849104616     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio:2008029     Document Type: Article

References (29)

1. Almeida R., Levery S. B., Mandel U., Kresse H., Schwientek T., Bennett E. P. & Clausen H. Cloning and expression of a proteoglycan UDP-galactose :betaxylose β1,4-galactosyltransferase I. A seventh member of the human β4-galactosyltransferase gene family. J Biol Chem, 1999, 274, 26165-26171.
2. Bai X., Zhou D., Brown J. R., Crawford B. E., Hennet T. & Esko J. D. Biosynthesis of the linkage region of glycosaminoglycans : cloning and activity of galactosyltransferase II, the sixth member of the β1,3- galactosyltransferase family (β3GalT6). J Biol Chem, 2001, 276, 48189-48195.
3. Barŕe L., Venkatesan N., Magdalou J., Netter P., Fournel-Gigleux S. & Ouzzine M. Evidence of calcium dependent pathway in the regulation of human β1,3-glucuronosyltransferase-1 (GlcAT-I) gene expression: a key enzyme in proteoglycan synthesis. FASEB J, 2006, 20, 963-975.
4. Bayliss M.T., Osborne D., Woodhouse S. & Davidson C. Sulfation of chondroitin sulfate in human articular cartilage. Effet of age, topographical position, and zone of cartilage on tissue composition. J Biol Chem, 1999, 274, 15892-15900.
5. Calabro A., Midura R., Wang A., West L., Plaas A. & Hascall V. C. Fluorophore-assisted carbohydrate electrophoresis (FACE) of glycosaminoglycans. Osteoarthritis & Cartilage, 2001, 9, 16-22.
6. Dudhia J. Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci, 2005, 62, 2241-2256.
7. Fondeur-Gelinotte M., Lattard V., Oriol R., Mollicone J.-C., Jacquinet J.-C., Mulliert G., Gulberti S., Netter P., Magdalou J., Ouzzine M. & Fournel-Gigleux S. Phylogenetic and mutational analyses reveal key residues for UDP-glucuronic acid binding and activity of β1,3-glucuronosyltransferase I (GlcAT-I). Protein Sci, 2006, 15, 1667-1678.
8. Fondeur-Gelinotte M., Lattard V., Gulberti S., Oriol R, Mulliert G., Coughtrie M. W., Magdalou J., Netter P., Ouzzine M. & Fournel-Gigleux S. Molecular basis for acceptor substrate specificity of the human β1,3-glucuronosyltransferases GlcAT-I and GlcAT-P involved in glycosaminoglycan and HNK-1 carbohydrate epitope biosynthesis, respectively. Glycobiology, 2007, 17, 857-867.
9. Glasson S. S. In vitro osteoarthritis validation utilizing genetically-modified mice. Curr Drug Target, 2007, 8, 367-376.
10. G̈otting C., Kuhn J., Zahn R., Brinkmann T. & Kleesiek K. Molecular cloning and expression of human UDP-D-xylose : proteoglycan core protein β-Dxylosyltransferase and its first isoform XT-II. J Mol Biol, 2000, 304, 517-528.
11. Gouze J.-N., Bordji K., Gulberti S., Terlain B., Netter P., Magdalou J., Fournel-Gigleux S. & Ouzzine M. Interleukin 1β down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis : influence of glucosamine on interleukin 1β-mediated effects in rat chondrocytes. Arthritis Rheum, 2001, 44, 351-360.
12. Grossin L., Cournil-Henrionnet C., Pinzano A., Gaborit N., Dumas D., Etienne S., Stoltz J.-F., Terlain B., Netter P., Mir L. M. & Gillet P. Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis. FASEB J, 2006, 20, 65-75.
13. Gulberti S., Fournel-Gigleux S., Mulliert G., Aubry A., Netter P., Magdalou J. & Ouzzine M. The functional glycosyltransferase signature sequence of the human β1,3-glucuronosyltransferase is a XDD motif. J Biol Chem, 2003, 278, 32219-33226.
14. Gulberti S., Lattard V., Fondeur M., Jacquinet J.-C., Mulliert G., Netter P., Magdalou J., Ouzzine M. & Fournel-Gigleux S. Phosphorylation and sulfation of oligosaccharide substrates critically influence the activity of human β1,4-galactosyltransferase 7 (GalT-I) and β1,3- glucuronosyltransferase I (GlcAT-I) involved in the biosynthesis of glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem, 2005, 280, 1417-1425.
15. Holderbaum D., Haqqi T. M. & Moskowitz R. W. Genetics and osteoarthritis : exposing the iceberg. Arthrtis Rheum, 1999, 42, 397-405.
16. Jacquinet J.-C. Synthesis of a set of sulfated and/or phosphorylated oligosaccharide derivatives from the carbohydrate-protein linkage region of proteoglycans. Carbohydr Res, 2006, 341, 1630-1644.
17. Kisilevsky R., Szareck W. A., Ancsin J. B., Elimova E., Marone S., Bhat S. & Berkin A. Inhibition of amyloid A amiloidogenesis in vitro in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-β- and β-D-glucose: implications for the treatment of various amyloidoses. Am J Pathol, 2004, 164, 2127-2137.
18. Kitagawa H., Taoka M., Tone Y., & Sugahara K. Human glycosaminoglycan glucuronyltransferase I gene and a related processed pseudogene: genomic structure, chromosomal mapping and characterization. Biochem J, 2001, 358, 539-546.
19. Kolset S. O., Sakurai K., Ivhed I., Overvatn A. & Suzuki S. The effect of β-D-xylosides on the proliferation and proteoglycan biosynthesis of monoblastic U-937 cells. Biochem J, 1990, 265, 637-645.
20. Lenz R. W., Ax R. I. & First N. L. Proteoglycan production by bovine granula cells in vitro is regulated by calmodulin and calcium. Endocrinology, 1982, 110, 1052-1054.
21. Martin N. B., Masson P., Sepulchre C., Theveniaux J., Millet & Bellamy F. Pharmacologic and biochemical profiles of new venous antithrombotic β-D-xylosides derivatives : potential antiathero/thrombotic drugs. Semin Thromb Hemost, 1996, 22, 247-254.
22. Mosyak L., Georgiadis K., Shane T., Svenson K., Hebert T., McDonagh T., Mackie S., Olland S., Lin L., Zhong X., Kriz R., Reifenberg E. L., Collins-Racie L. A., Corcoran C., Freeman B., Zollner R., Marvell T., Vera M., Sum P.-E., Lavallie E. R., Stahn M. & Somers W. Crystal structure of the two major aggrecan degrading enzymes, ADMTS4 and ADAMTS5. Protein Sci, 2007, 17, 16-21.
23. Ouzzine M., Gulberti S., Levoin N., Netter P., Magdalou J. & Fournel-Gigleux S. The donor substrate specificity of the human ? 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residues. J Biol Chem, 2002, 277, 25439-25445.
24. Sobue M., Habuchi H., Ito K., Yonekura H., Oguri K., Sakurai K., Kamohara S. Ueno Y., Noyori R. & Suzuki S. β-D-xylosides and their analogues as artificial initiators of glycosaminoglycan chain synthesis. Aglyconerelated variation in their effectiveness in vitro and in ovo. Biochem J, 1987, 241, 591-601.
25. Sugahara K. & Kitagawa H. Heparin and heparan sulfate biosynthesis. I U B M B Life, 2002, 54, 163-175.
26. Venkatesan N., Barŕe L., Benani A., Netter P., Magdalou J., Fournel-Gigleux S. & Ouzzine M. Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a novel strategy to promote cartilage repair. Proc Natl Acad Sci USA, 2004, 101, 18087-18092.
27. Venkatesan N., Magdalou J., Netter P., Fournel-Gigleux S. & Ouzzine M. Stimulation de la biosynth̀ese des prot́eoglycanes : une nouvelle strat́egie pour la ŕeparation du cartilage articulaire. Ḿedecine/Sciences, 2005, 21, 471-473.
28. Vertel B. M., Walters L. M., Flay N., Kearns A. E. & Schwartz N. B. Xylosylation is an endoplasmic reticulum to Golgi event. J Biol Chem, 1993, 268, 11105-11112.
29. Vijayagopal P. & Bubramaniam P. Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoproteinproteoglycan interactions. Atherosclerosis, 2001, 157, 353-360.